TORONTO (AP) — TORONTO (AP) — OrganiGram Holdings Inc. (OGI) on Wednesday reported a loss of $4 million in its fiscal fourth quarter. The Toronto-based company said it had a loss of 4 cents per share. The cannabis producer posted revenue of $32.8 million in the period. For the year, the company reported a loss of $33.4 million, or 35 cents per share. Revenue was reported as $117.5 million. _____ This story was generated by  Automated Insights  (…

Benzinga

New York

United States

Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars - OrganiGram Holdings (NASDAQ:OGI)

Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.

Ad Fontes Media

Media Bias/Fact Check

All Sides

Washington Top News

Hubbard Broadcasting

Washington

District of Columbia

OrganiGram: Fiscal Q4 Earnings Snapshot

Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.

MarketWatch

Murdoch family

Canada’s Organigram shops for U.S. pot businesses with backing from British American Tobacco

Green Stock News for the New Green Economy.

Green Stock News

Organigram Reports Fourth Quarter and Fiscal 2024 Results

Organigram Holdings Inc. (Nasdaq: OGI) beat analyst expectations Wednesday off the heel of a major acquisition announcement, despite remaining in the red for now. The Toronto-based producer posted fiscal fourth-quarter revenue of C$44.7 million that beat Yahoo Finance’s average estimate of C$39.12 million. Still, the company reported a net loss of C$5.4... Please login to read all 388 words.

Green Market Report

Organigram tops estimates, expands international reach ahead of major deal

Organigram Reports Fourth Quarter and Fiscal 2024 Results Fiscal 2024 net revenue of $159.8 million 17.6% year-over-year growth in Organigram’s recreational shipped sales in Fiscal 2024 Q4 Fiscal 2024 adjusted gross margin¹ of 37% Q4 Fiscal 2024 adjusted EBITDA² of $5.9 million or 13% of net revenue Q4 Fiscal 2024 cash flow from operations of […]

New Cannabis Ventures

Organigram Increases Revenue and Adjusted EBITDA in Q4

Organigram (NASDAQ:OGI – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01), Zacks reports. Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%. Organigram Price Performance OGI traded up $0.01 on Wednesday, […]

themarketsdaily.com

Organigram (NASDAQ:OGI) Issues Quarterly  Earnings Results

Organigram (NASDAQ:OGI – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01), Zacks reports. Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%. Organigram Trading Up 7.5 % OGI stock opened at […]

watchlistnews.com

Organigram (NASDAQ:OGI) Posts  Earnings Results, Misses Estimates By $0.01 EPS

Organigram Reports Fourth Quarter and Fiscal 2024 Results Fiscal 2024 net revenue of $159.8 million 17.6% year-over-year growth in Organigram's recreational shipped sales in Fiscal 2024 Q4 Fiscal 2024 adjusted gross margin¹ of 37% Q4 Fiscal 2024 adjusted EBITDA of $5.9 million or 13% of net revenue Q4 Fiscal 2024 cash flow from operations of [ . . . ]

newsbudz.com

Organigram Reports Fourth Quarter and Fiscal 2024 Results Fiscal 2024 net revenue of $159.8 million 17.6% year-over-year growth in Organigram’s recreational shipped sales in Fiscal 2024 Q4 Fiscal 2024 adjusted gross margin¹ of 37% Q4 Fiscal 2024 adjusted EBITDA² of $5.9 million or 13% of net revenue Q4 Fiscal 2024 cash flow from operations of

OrganiGram: Fiscal Q4 Earnings Snapshot

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics